corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items where at least one author is a Healthy Skepticism member

Page 3 of 3 pages  < 1 2 3

HSL1418
Jureidini J, Tonkin A.
Paroxetine in major depression.
J Am Acad Child Adolesc Psychiatry 2003 May;42:(5):514
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0890-8567&volume=42&issue=5&spage=514

HSL1233
Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP.
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
CMAJ 2003 Apr 29;168:(9):1133-7
http://www.cmaj.ca/cgi/content/full/168/9/1133

HSL1415
Jureidini JN, Tonkin AL.
Clinical practice guidelines for depression in young people.
Med J Aust 2003 Mar 17;178:(6):300
http://www.mja.com.au/public/issues/178_06_170303/letters_170303-5.html

HSL1188
Mansfield PR, Lexchin J, Vitry A, Doecke CJ, Svensson S.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361:(9360):879
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-48400HM-1B&_coverDate=03%2F08%2F2003&_alid=272642718&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4886&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=fa10917712438764944ab5277ec07357

HSL5591
Russell FM, Shann F, Curtis N, Mulholland K.
Evidence on the use of paracetamol in febrile children.
Bull World Health Organ 2003;81:(5):367-72
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862003000500011&lng=en&nrm=iso&tlng=en

HSL2256
Jureidini J, Mansfield PR.
Avoiding competing interests
BMJ 2002 Dec 27;325:(7377):1375
http://bmj.com/cgi/eletters/325/7377/1375

HSL1920
Vitry AI, Hurley E.
The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors.
Med J Aust 2002 Nov 18;177:(10):572-3
http://www.mja.com.au/public/issues/177_10_181102/vitry_181102.html

HSL1419
Jureidini J.
Does the International Consensus Statement on ADHD leave room for healthy scepticism?
Eur Child Adolesc Psychiatry 2002 Oct;11:(5):240

HSL1892
Molloy W, Strang D, Guyatt G, Lexchin J, Bedard M, Dubois S, Russo R.
Assessing the quality of drug detailing.
J Clin Epidemiol 2002 Aug;55:(8):825-32

HSL17906
Moynihan R
Celebrity selling
BMJ 2002 Jun 1;324:(7349):1342
http://www.bmj.com/cgi/content/citation/324/7349/1342?HITS=10&hits=10&stored;_search=&author1=Moynihan%2C%2BR&maxtoshow;=&FIRSTINDEX=0&resourcetype=1,2,3,4,10&searchid=1023661467365_9984&RESULTFORMAT;=

HSL5849
Toop L, Richards D.
DTCA in New Zealand: the challenge of finding an acceptable balance
Br J Gen Pract. 2002 Apr 1;52:(477):341

HSL5592
Shann F.
Research in developing countries.
N Engl J Med 2002 Feb 21;346:(8):627-8

HSL27
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
BMJ 2002;324:278-279
http://bmj.bmjjournals.com/cgi/content/full/324/7332/278

HSL2148
WHO Department of Essential Drugs & Medicines Policy
Drug Promotion Database
: WHO Department of Essential Drugs & Medicines Policy 2002
http://www.drugpromo.info/

HSL13290
Lexchin J, Mintzes B.
Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No
Journal of Public Policy and Marketing 2002;21:(2):194-201
http://web.archive.org/web/20080511145449/http://www.marketingpower.com/content18627.php

HSL5593
Shann F.
Uses of error: the wrong research costs lives.
Lancet 2001 May 26;357:(9269):1691
http://linkinghub.elsevier.com/retrieve/pii/S0140673600048790

HSL34
Vlassov V, Mansfield P, Lexchin J, Vlassova A.
Do drug advertisements in Russian medical journals provide essential information for safe prescribing?
West J Med 2001;174:391-394

HSL2156
Jureidini J, Mansfield P.
Does drug promotion adversely influence doctors’ abilities to make the best decisions for patients?
Australasian Psychiatry 2001;9:95-99
http://www.blackwell-synergy.com/doi/full/10.1046/j.1440-1665.2001.00313.x?prevSearch=allfield%3A%28Jureidini+J+and+Mansfield+P%29

HSL6960
Gifts: a transcript of a television report
MaLAM International News 2000 Sep-Oct;18:(9-10):1-4

HSL19762
Mansfield P
Sickening sales pitch of the drug marketeers
The Sydney Morning Herald 2000 July 3
http://newsstore.smh.com.au/apps/viewDocument.ac?page=1&sy=smh&kw=Sickening+sales+pitch+of+the+drug&pb=smh&dt=selectRange&dr=entire&so=relevance&sf=text&sf=headline&rc=10&rm=200&sp=nrm&clsPage=1&docID=news000703_0087_8149

HSL856
Irwig LM, Loy CT, Chapman S, Glasziou PP, Mansfield PR, Salkeld GP, Walton MM.
!nform test kits distributed with the MJA.
Med J Aust 2000 May 15;172:(10):518-9

HSL2242
Roughead L, Semple S, Vitry A.
The Value of Pharmacist Professional Services in the Community: A systematic review of the literature 1990-2002
2000

HSL20171
Mansfield P
Debate: drug advertising: No
Australian Doctor 1999 Oct 864

HSL1032
Lexchin J.
Don't bite the hand that feeds you.
West J Med 1999 Oct;171:(4):238-9
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=10578675

HSL6891
Memoirs of methods used to sell drugs
MaLAM International News 1999 Mar-Apr;17:(3-4):1-6

HSL6888
Advertising of antibacterials
Health Skepticism 1999 Feb;2:(2):1-5

HSL6886
Advertising of CCBs for hypertension
Health Skepticism 1999 Jan;2:(1):3-4

HSL394
Lexchin J.
Drug not considered a first-line agent.
Can Fam Physician 1998 Nov;44:2376

HSL6832
ACE inhibitors
Health Skepticism 1998 Nov;1:(1):3-4

HSL396
Lexchin J.
Intellectual property rights and drug prices.
Lancet 1998 Aug 15;352:(9127):582
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-4FWV34C-NC&_coverDate=08%2F15%2F1998&_alid=305534210&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4886&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=85140d6e65b19947f465cc4160cdcac0

HSL393
Lexchin J.
Residents and pharmaceutical representatives.
Can Fam Physician 1998 Jul;44:1448:

HSL6816
MaLAM letter follow up—MaLAM apologises but we remain concerned about thepromotion of Atarax
MaLAM International News 1998 Jul-Aug;16:(7-8):1-5

HSL20519
Sweet M
New fears on doctors' links to drug firms
The Sydney Morning Herald 1998 Jan 233

HSL395
Lexchin J.
Improving the appropriateness of physician prescribing.
Int J Health Serv 1998;28:(2):253-67

HSL1550
Mansfield PR.
MaLAM, a medical lobby for appropriate marketing of pharmaceuticals.
Med J Aust 1997 Dec 1-15;167:(11-12):590-2
http://www.mja.com.au/public/issues/xmas/mansfield/mansfield.html

HSL6776
Mansfield P, Vitry A.
Re: the promotion of prescription products in Australia
1997 Dec;

HSL418
Vitry A, Mansfield P.
Drug advertisements in medical journals.
Lancet 1997 Nov 15;350:(9089):1477-8
http://www.thelancet.com/search/results?search_searchuri=%2Fsearch%2Fadvanced&search_resulturi=%2Fsearch%2Fresults&search_preview=no&search_reqfirst=1&search_reqcount=20&search_submode=advanced&update_search=no&search_mode=platform&search_cluster=phoenix&search_text1=Vitry+A&search_within1=au&search_operator1=and&search_text2=Mansfield+P&search_within2=au&search_operator2=and&search_text3=advertisements&search_within3=ti&restrictterm_lancet=lancet&restrictname_lancet=lancet&restricttype_lancet=journal&restrictdesc_lancet=The+Lancet&restrictname_laneur=laneur&restricttype_laneur=journal&restrictdesc_laneur=The+Lancet+Neurology&restrictname_laninf=laninf&restricttype_laninf=journal&restrictdesc_laninf=The+Lancet+Infectious+Diseases&restrictname_lanonc=lanonc&restricttype_lanonc=journal&restrictdesc_lanonc=The+Lancet+Oncology&search_dateradio=combo&search_datecombo=0%3AALL&search_monthstartcombo=1&search_yearstart=1996&search_monthendcombo=1&search_yearend=2005&search_wordsexactly=yes&search_sort=relevance&Submit=Search

HSL545
Lexchin J.
Code of marketing practices.Voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada
Can Fam Physician. 1997 11 01;43:

HSL1894
Lexchin J.
What information do physicians receive from pharmaceutical representatives?
Can Fam Physician 1997 May;43:941-5

HSL392
Lexchin J.
[Pharmaceutic regulation and inadequate drug prescription in Canada: the case of psychotropic drugs in the 1960s and early 1970s]
Sante Ment Que. 1997 Spring;22:(1):283-300

HSL547
Lexchin J.
Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
CMAJ 1997 Feb 1;156:(3):351-6
http://www.cmaj.ca/cgi/reprint/156/3/351

HSL520
Shear NH, Black F, Lexchin J.
Physician-detailer interaction—II.
Can J Clin Pharmacol 1997;4:(1):10

HSL538
Mansfield P, Lexchin J.
MaLAM: networking for scientific integrity in drug promotion.
Essential Drugs Monitor 1997(24):5
http://web.archive.org/web/20080511183432/http://healthyskepticism.org/library/EDM/24/Page5.pdf

HSL539
Mansfield P.
Can health professionals lobby drug companies to upgrade from misleading promotion to reliable service?
Australian Prescriber 1997;20:(Supp 1):150

HSL546
Lexchin J.
Recent progress in drug advertising
Can Fam Physician 1997;43:1041-1042

HSL585
Vitry A, Mansfield P.
Promotion of Coversyl by Servier.
Lancet 1996 May 18;347:(9012):1411

HSL639
Anderson GM, Lexchin J.
Strategies for improving prescribing practice.
CMAJ 1996 Apr 1;154:(7):1013-7
http://www.cma.ca/cmaj/vol-154/1013e.htm

HSL586
Vitry A.
Pharmaceutical promotion: drug advertising affects your prescribing
Australian Prescriber 1996;19:103

HSL594
Shear NH, Black F, Lexchin J.
Examining the physician-detailer interaction
Can J Clin Pharmacol 1996;3:(4):175-179

HSL609
Lexchin J.
Direct to consumer advertising of prescription drugs: the next steps
Can J Clin Pharmacol 1996;3:(2):65

HSL364
Lexchin J.
Deception by design: Pharmaceutical promotion in the Third World
Penang: Consumers International 1995

HSL667
Lexchin J.
Is there a bias in industry supported clinical research
Can J Clin Pharmacol 1995;2:15-18

HSL6149
Lexchin J.
Agents against pediatric diarrhea. Assessing the information companies supply to Canadian physicians
Can Fam Physician. 1994 Dec 01;40:2082-7

HSL6155
Mansfield PR.
MaLAM: encouraging trustworthy drug promotion
Essential Drugs Monitor 1994;(17):6

HSL2157
Lexchin J.
Interactions between physicians and the pharmaceutical industry: what does the literature say?
CMAJ 1993 Nov 15;149:(10):1401-7
http://www.cmaj.ca/cgi/content/abstract/149/10/1401?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Lexchin+J&andorexactfulltext=and&searchid=1124491359271_2918&stored_search=&FIRSTINDEX=0&sortspec=relevance&resourcetype=1&journalcode=cmaj

HSL5164
Lexchin J.
Physicians and drug companies interact.
Can Fam Physician 1993 Sep 01;39:1881-2

HSL4641
Re: the promotion of aspirin
1992 Nov 1;

HSL3984
Wade VA, Mansfield PR, McDonald PJ.
Drug companies' evidence to justify advertising.
Lancet 1989 Nov 25;2:(8674):1261-3

HSL857
Mansfield PR.
Drug advertising.
Lancet 1989 May 20;1:(8647):1137-8

HSL2055
Mansfield PR.
Drug Advertising
Med J Aust 1987 Jun 15;146:(12):660-661

HSL861
Mansfield P.
Phenylbutazone.
Med J Aust 1986 Jan 6;144:(1):55

HSL20475
Mansfield PR
Phenylbutazone
Medical Journal of Australia 1986 Jan 6;144:55

HSL862
Mansfield P.
Phenylbutazone.
Med J Aust 1985 Sep 2;143:(5):219-20

HSL20483
MLAM
Round the World: From our Correspondents: Australia: MLAM
Lancet 1984 Oct 13;861

HSL19755
Lexchin J.
Lifestyle drugs: issues for debate.
CMAJ 2001 15;164:(10):1449-51
http://www.cmaj.ca/content/164/10/1449.long

HSL19873
Mansfield P
Pushing expensive new drugs
Consuming Interest 2001 00 00;

HSL19874
Mansfield P
Pushing expensive new drugs
Consuming Interest 20010

HSL20469
Mansfield PR
Drug Marketing in the Third World
National News The Royal College of General Practitioners 1984 Aug

HSL20476
Ideas for Action: MLAM
New Internationalist 1984 Apr29
http://newint.org/features/1984/04/05/action/

HSL20480
Protecting The Innocent From Harm: The Medical Lobby for Appropriate Marketing (MLAM)
New Doctor ?198522, 23

Page 3 of 3 pages  < 1 2 3

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909